$RGNX Cashflow Statement | Understand Stock

$RGNX

$6.60 +$0.02 (0.3%) Close

$RGNX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities
Net loss
Adjustments to reconcile net loss to net cash used in operating activities
Stock-based compensation expense
Depreciation and amortization
Provision for credit losses (recoveries)
Net accretion of discounts on marketable debt securities
Net realized gain on investments
Imputed interest income from licensing
Impairment of long-lived assets
Non-cash interest expense
Other non-cash adjustments

Changes in operating assets and liabilities
Accounts receivable
Prepaid expenses
Other current assets
Operating lease right-of-use assets
Other assets
Accounts payable
Accrued expenses and other current liabilities
Deferred revenue
Operating lease liabilities
Other liabilities
Net cash used in operating activities
Cash flows from investing activities
Purchases of marketable debt securities
Maturities of marketable debt securities
Sales of equity securities
Purchases of property and equipment
Net cash provided by (used in) investing activities
Cash flows from financing activities
Proceeds from exercise of stock options
Taxes paid related to net settlement of stock options
Taxes paid related to net settlement of stock-based awards
Proceeds from issuance of common stock under employee stock purchase plan
Proceeds from public offering of common stock, net of underwriting discounts and commissions
Proceeds from public offering of common stock and pre-funded warrants, net of issuance costs
Expenses related to at-the-market offering programs
Proceeds from issuance of royalty bond and warrants, net of transaction costs
Proceeds from private placement of common stock, net of issuance costs
Offering expenses related to at-the-market offering programs
Issuance costs for public offering of common stock
Transaction costs for sale of future royalties
Repayments under liability related to sale of future royalties, net of imputed interest
Repayments under royalty monetization liabilities, net of interest
Net cash provided by financing activities

Net increase (decrease) in cash and cash equivalents and restricted cash
Cash and cash equivalents and restricted cash
Beginning of period
End of period
Supplemental cash flow information
Cash paid (received) for income taxes
Cash paid for interest under royalty monetization liabilities
Supplemental disclosures of non-cash investing and financing information
Purchases of property and equipment in accounts payable and accrued expenses and other current liabilities
Proceeds due to Company from sales of non-marketable equity securities
Deferred equity offering costs in accounts payable and accrued expenses and other current liabilities
Deferred equity offering costs reclassified

Comments